Andrew Berens
Stock Analyst at Leerink Partners
(4.86)
# 370
Out of 4,609 analysts
528
Total ratings
48.7%
Success rate
24.7%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Downgraded: Hold | $48 → $52 | $52.68 | -1.29% | 13 | Aug 6, 2026 | |
| INCY Incyte | Maintained: Buy | $103 → $155 | $116.82 | +32.68% | 62 | Aug 3, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $32.09 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $35.48 | +12.76% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $7.41 | - | 28 | Jun 2, 2026 | |
| STRO Sutro Biopharma | Rated: Buy | $38 → $43 | $24.42 | +76.09% | 2 | May 15, 2026 | |
| TNGX Tango Therapeutics | Rated: Buy | $10 → $55 | $28.83 | +90.81% | 26 | May 15, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 → $33 | $25.59 | +28.98% | 14 | May 15, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $46 → $51 | $30.05 | +69.72% | 2 | May 15, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $23 | $13.19 | +74.44% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $8.80 | +365.91% | 3 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.38 | +48.70% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $40 | $23.29 | +71.75% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $97 | $92.83 | +4.49% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $41.36 | +20.89% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.39 | +241.69% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $36.38 | -9.29% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.45 | - | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $4.03 | +719.88% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $19.56 | -38.65% | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $1.89 | +270.37% | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $2.90 | +3.63% | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $327.72 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $8.59 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $5.00 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $10.33 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $159.29 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $72.14 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 → $25 | $3.62 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $15.83 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.15 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $8.02 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $109.55 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $8 | $8.71 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.47 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9418 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $48.84 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $129.87 | n/a | 3 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.30 | n/a | 2 | Dec 1, 2014 |
Exelixis
Aug 6, 2026
Downgraded: Hold
Price Target: $48 → $52
Current: $52.68
Upside: -1.29%
Incyte
Aug 3, 2026
Maintained: Buy
Price Target: $103 → $155
Current: $116.82
Upside: +32.68%
Agios Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: n/a
Current: $32.09
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $35.48
Upside: +12.76%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.41
Upside: -
Sutro Biopharma
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $24.42
Upside: +76.09%
Tango Therapeutics
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $28.83
Upside: +90.81%
Immunome
May 15, 2026
Maintained: Buy
Price Target: $40 → $33
Current: $25.59
Upside: +28.98%
Damora Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $46 → $51
Current: $30.05
Upside: +69.72%
Adlai Nortye
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $13.19
Upside: +74.44%
Mar 6, 2026
Reiterated: Buy
Price Target: $41
Current: $8.80
Upside: +365.91%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $5.38
Upside: +48.70%
Nov 19, 2025
Maintained: Buy
Price Target: $24 → $40
Current: $23.29
Upside: +71.75%
Nov 17, 2025
Maintained: Buy
Price Target: $70 → $97
Current: $92.83
Upside: +4.49%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $41.36
Upside: +20.89%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $4.39
Upside: +241.69%
Oct 21, 2025
Maintained: Hold
Price Target: $30 → $33
Current: $36.38
Upside: -9.29%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $17.45
Upside: -
Aug 13, 2025
Maintained: Buy
Price Target: $33
Current: $4.03
Upside: +719.88%
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $19.56
Upside: -38.65%
Aug 12, 2025
Maintained: Buy
Price Target: $7
Current: $1.89
Upside: +270.37%
Aug 11, 2025
Maintained: Hold
Price Target: $3
Current: $2.90
Upside: +3.63%
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $327.72
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $9
Current: $8.59
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $5.00
Upside: n/a
Aug 5, 2025
Maintained: Buy
Price Target: $18.00
Current: $10.33
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $159.29
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: n/a
Current: $72.14
Upside: n/a
Feb 7, 2023
Maintained: Buy
Price Target: $67 → $25
Current: $3.62
Upside: n/a
Feb 7, 2023
Maintained: Hold
Price Target: $20 → $15
Current: $15.83
Upside: n/a
Mar 21, 2022
Maintained: Buy
Price Target: n/a
Current: $6.15
Upside: n/a
May 7, 2021
Maintained: Hold
Price Target: $10
Current: $8.02
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Maintained: Hold
Price Target: $23
Current: $109.55
Upside: n/a
Jul 14, 2017
Maintained: Hold
Price Target: $16 → $8
Current: $8.71
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $7.47
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.9418
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $48.84
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $129.87
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $13.30
Upside: n/a